Related Experiment Videos
Horse chestnut:a multidisciplinary clinical review
Natasha Tiffany1, Heather Boon, Catherine Ulbricht
1Natural Standard Research Collaboration, Cambridge, MA 02138-5204, USA.
Journal of Herbal Pharmacotherapy
|July 28, 2004
Summary
Horse chestnut seed extract effectively manages chronic venous insufficiency (CVI), showing superiority over placebo. It is comparable to compression stockings and oral oxerutins for CVI treatment.
Area of Science:
- Pharmacology and Phytotherapy
- Vascular Medicine
Background:
- Horse chestnut seed extract (HCSE) is a common European treatment for chronic venous insufficiency (CVI).
- Scientific evidence strongly supports HCSE specifically for CVI management.
Purpose of the Study:
- To review the scientific literature on the efficacy of horse chestnut seed extract for chronic venous insufficiency.
- To evaluate the quality of existing randomized controlled trials (RCTs) on HCSE for CVI.
Main Methods:
- Literature review of 14 randomized controlled trials (RCTs) concerning HCSE for CVI.
- Assessment of methodological quality, sample size, and duration of included studies.
Main Results:
- Seven high-quality RCTs indicate HCSE is superior to placebo for CVI.
- HCSE demonstrated comparable efficacy to compression stockings and oral oxerutins.
- Limitations include small sample sizes and short study durations in current trials.
Conclusions:
- Horse chestnut seed extract (HCSE) is an effective treatment for chronic venous insufficiency (CVI).
- Further large-scale, long-term trials are needed to confirm efficacy and safety against standard care.
- Other parts of the horse chestnut plant are not recommended due to toxicity.